F.D.A. Panel Recommends Approval for Gene-Altering Leukemia Treatment
By DENISE GRADY
If accepted, which is likely, it will be the first gene therapy ever to reach the market. “This is the beginning of something big,” a doctor said.
Published in Health on July 11, 2017 at 06:00PMRead more on The New York Times
Get an email from the New York Times whenever there is breaking technology news